Billet Isabelle 4
4 · Axogen, Inc. · Filed Mar 18, 2022
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Billet Isabelle
Chief Strategy and BD Officer
Transactions
- Tax Payment
Common Stock
2022-03-16$7.97/sh−2,447$19,503→ 21,769 total - Exercise/Conversion
Restricted Stock Units
2022-03-16−8,500→ 8,500 totalFrom: 2024-03-16→ Common Stock (8,500 underlying) - Award
Restricted Stock Units
2022-03-16+23,354→ 23,354 total→ Common Stock (23,354 underlying) - Exercise/Conversion
Common Stock
2022-03-16+8,500→ 24,216 total - Award
Employee Stock Option (right to purchase)
2022-03-16+21,784→ 21,784 totalExercise: $8.20Exp: 2032-03-16→ Common Stock (21,784 underlying)
Footnotes (6)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2022.
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F5]All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 16, 2026 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2024 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.